BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 34958974)

  • 1. Antibiotic Exposure, Not Alloreactivity, Is the Major Driver of Microbiome Changes in Hematopoietic Cell Transplantation.
    Bansal R; Park H; Taborda CC; Gordillo C; Mapara MY; Assal A; Uhlemann AC; Reshef R
    Transplant Cell Ther; 2022 Mar; 28(3):135-144. PubMed ID: 34958974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of intestinal microbiota in antithymocyte globulin-based myeloablative allogeneic hematopoietic cell transplantation.
    Gu Z; Xiong Q; Wang L; Wang L; Li F; Hou C; Dou L; Zhu B; Liu D
    Cancer; 2022 Apr; 128(7):1402-1410. PubMed ID: 35077579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a North American multicentre collaborative study.
    Kharfan-Dabaja MA; Al Malki MM; Deotare U; Raj RV; El-Jurdi N; Majhail N; Cherry MA; Bashir Q; Darrah J; Nishihori T; Sibai H; Hamadani M; de Lima M; Gerds AT; Selby G; Qazilbash MH; Forman SJ; Ayala E; Lipton JH; Hari PN; Muzzafar T; Zhang L; Olteanu H; Perkins J; Sokol L; Kumar A; Ahmed S
    Br J Haematol; 2017 Dec; 179(5):781-789. PubMed ID: 28980314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous or reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chemotherapy-sensitive mantle-cell lymphoma: analysis of transplantation timing and modality.
    Fenske TS; Zhang MJ; Carreras J; Ayala E; Burns LJ; Cashen A; Costa LJ; Freytes CO; Gale RP; Hamadani M; Holmberg LA; Inwards DJ; Lazarus HM; Maziarz RT; Munker R; Perales MA; Rizzieri DA; Schouten HC; Smith SM; Waller EK; Wirk BM; Laport GG; Maloney DG; Montoto S; Hari PN
    J Clin Oncol; 2014 Feb; 32(4):273-81. PubMed ID: 24344210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced-Intensity Allografting as First Transplantation Approach in Relapsed/Refractory Grades One and Two Follicular Lymphoma Provides Improved Outcomes in Long-Term Survivors.
    Klyuchnikov E; Bacher U; Kröger NM; Hari PN; Ahn KW; Carreras J; Bachanova V; Bashey A; Cohen JB; D'Souza A; Freytes CO; Gale RP; Ganguly S; Hertzberg MS; Holmberg LA; Kharfan-Dabaja MA; Klein A; Ku GH; Laport GG; Lazarus HM; Miller AM; Mussetti A; Olsson RF; Slavin S; Usmani SZ; Vij R; Wood WA; Maloney DG; Sureda AM; Smith SM; Hamadani M
    Biol Blood Marrow Transplant; 2015 Dec; 21(12):2091-2099. PubMed ID: 26253007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Fructo-Oligosaccharide Prebiotic Is Well Tolerated in Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Phase I Dose-Escalation Trial.
    Andermann TM; Fouladi F; Tamburini FB; Sahaf B; Tkachenko E; Greene C; Buckley MT; Brooks EF; Hedlin H; Arai S; Mackall CL; Miklos D; Negrin RS; Fodor AA; Rezvani AR; Bhatt AS
    Transplant Cell Ther; 2021 Nov; 27(11):932.e1-932.e11. PubMed ID: 34274493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecal microbiota diversity disruption and clinical outcomes after auto-HCT: a multicenter observational study.
    Khan N; Lindner S; Gomes ALC; Devlin SM; Shah GL; Sung AD; Sauter CS; Landau HJ; Dahi PB; Perales MA; Chung DJ; Lesokhin AM; Dai A; Clurman A; Slingerland JB; Slingerland AE; Brereton DG; Giardina PA; Maloy M; Armijo GK; Rondon-Clavo C; Fontana E; Bohannon L; Ramalingam S; Bush AT; Lew MV; Messina JA; Littmann E; Taur Y; Jenq RR; Chao NJ; Giralt S; Markey KA; Pamer EG; van den Brink MRM; Peled JU
    Blood; 2021 Mar; 137(11):1527-1537. PubMed ID: 33512409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allogeneic hematopoietic cell transplantation for diffuse large B cell lymphoma: who, when and how?
    Klyuchnikov E; Bacher U; Kroll T; Shea TC; Lazarus HM; Bredeson C; Fenske TS
    Bone Marrow Transplant; 2014 Jan; 49(1):1-7. PubMed ID: 23708703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autologous/Allogeneic Hematopoietic Cell Transplantation versus Tandem Autologous Transplantation for Multiple Myeloma: Comparison of Long-Term Postrelapse Survival.
    Htut M; D'Souza A; Krishnan A; Bruno B; Zhang MJ; Fei M; Diaz MA; Copelan E; Ganguly S; Hamadani M; Kharfan-Dabaja M; Lazarus H; Lee C; Meehan K; Nishihori T; Saad A; Seo S; Ramanathan M; Usmani SZ; Gasparetto C; Mark TM; Nieto Y; Hari P
    Biol Blood Marrow Transplant; 2018 Mar; 24(3):478-485. PubMed ID: 29079457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gut microbiota and graft-versus-host disease: broad-spectrum antibiotic use increases post-allogeneic hematopoietic stem cell transplant graft-versus-host disease-related mortality].
    Shono Y
    Rinsho Ketsueki; 2017; 58(7):835-842. PubMed ID: 28781282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conditioning Regimens are Associated with Distinct Patterns of Microbiota Injury in Allogeneic Hematopoietic Cell Transplantation.
    Shouval R; Waters NR; Gomes ALC; Zuanelli Brambilla C; Fei T; Devlin SM; Nguyen CL; Markey KA; Dai A; Slingerland JB; Clurman AG; Fontana E; Amoretti LA; Wright RJ; Hohl TM; Taur Y; Sung AD; Weber D; Hashimoto D; Teshima T; Chao NJ; Holler E; Scordo M; Giralt SA; Perales MA; Peled JU; van den Brink MRM
    Clin Cancer Res; 2023 Jan; 29(1):165-173. PubMed ID: 36322005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-World Economic Burden Associated with Transplantation-Related Complications.
    Perales MA; Bonafede M; Cai Q; Garfin PM; McMorrow D; Josephson NC; Richhariya A
    Biol Blood Marrow Transplant; 2017 Oct; 23(10):1788-1794. PubMed ID: 28688917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reconstitution of the gut microbiota of antibiotic-treated patients by autologous fecal microbiota transplant.
    Taur Y; Coyte K; Schluter J; Robilotti E; Figueroa C; Gjonbalaj M; Littmann ER; Ling L; Miller L; Gyaltshen Y; Fontana E; Morjaria S; Gyurkocza B; Perales MA; Castro-Malaspina H; Tamari R; Ponce D; Koehne G; Barker J; Jakubowski A; Papadopoulos E; Dahi P; Sauter C; Shaffer B; Young JW; Peled J; Meagher RC; Jenq RR; van den Brink MRM; Giralt SA; Pamer EG; Xavier JB
    Sci Transl Med; 2018 Sep; 10(460):. PubMed ID: 30257956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic Exposure Prior to Respiratory Viral Infection Is Associated with Progression to Lower Respiratory Tract Disease in Allogeneic Hematopoietic Cell Transplant Recipients.
    Ogimi C; Krantz EM; Golob JL; Waghmare A; Liu C; Leisenring WM; Woodard CR; Marquis S; Kuypers JM; Jerome KR; Pergam SA; Fredricks DN; Sorror ML; Englund JA; Boeckh M
    Biol Blood Marrow Transplant; 2018 Nov; 24(11):2293-2301. PubMed ID: 29777867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics comparisons of bacteremia in allogeneic and autologous hematopoietic stem cell-transplant recipients with levofloxacin prophylaxis and influence on resistant bacteria emergence.
    Wang CH; Chang FY; Chao TY; Kao WY; Ho CL; Chen YC; Dai MS; Chang PY; Wu YY; Lin JC
    J Microbiol Immunol Infect; 2018 Feb; 51(1):123-131. PubMed ID: 27103500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of Body Composition Following Autologous and Allogeneic Hematopoietic Cell Transplantation: Incidence of Sarcopenia and Association with Clinical Outcomes.
    DeFilipp Z; Troschel FM; Qualls DA; Li S; Kuklinski MW; Kempner ME; Hochberg E; Chen YB; El-Jawahri A; Fintelmann FJ
    Biol Blood Marrow Transplant; 2018 Aug; 24(8):1741-1747. PubMed ID: 29496561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subjective Oral Dryness following Hematopoietic Cell Transplantation: A Report from the Orastem Study.
    Bulthuis MS; van Leeuwen SJM; Thomas RZ; van Gennip LLA; Whiteside HM; Isom S; Kline DM; Laheij AMGA; Raber-Durlacher JE; Hasséus B; Johansson JE; Hovan AJ; Brennan MT; von Bültzingslöwen I; Huysmans MDNJM; Blijlevens NMA
    Transplant Cell Ther; 2024 Apr; 30(4):446.e1-446.e11. PubMed ID: 38242439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of Autologous and Allogeneic Hematopoietic Cell Transplantation in Adults with Acute Promyelocytic Leukemia: Results of a Systematic Review and Meta-Analysis.
    Mohty R; Reljic T; Yassine F; Kettaneh C; Al-Husni D; Keller K; Badar T; Murthy H; Foran J; Kumar A; Kharfan-Dabaja MA
    Transplant Cell Ther; 2024 Jun; 30(6):599.e1-599.e10. PubMed ID: 38554737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes in patients with relapsed or refractory acute promyelocytic leukemia treated with or without autologous or allogeneic hematopoietic stem cell transplantation.
    Pemmaraju N; Tanaka MF; Ravandi F; Lin H; Baladandayuthapani V; Rondon G; Giralt SA; Chen J; Pierce S; Cortes J; Kantarjian H; Champlin RE; De Lima M; Qazilbash MH
    Clin Lymphoma Myeloma Leuk; 2013 Aug; 13(4):485-92. PubMed ID: 23769669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.